ARTICLE | Company News
Paracelsian sales and marketing update
December 6, 1993 8:00 AM UTC
In Vivo-CDK determines whether a chemical is capable of converting normal cells into cancerous cells, PRLN said, by quantifying the amount of protein biomarker (cyclin-dependent kinases) in tissue. An...